The approaching mega-IPO cycle will function as a transient liquidity absorber across risk assets before post-lockup wealth ...

The IPO class of 2026 is likely to receive its first incumbent, after Aktis Oncology set its sights on a public listing that could see proceeds of around $210m. The cancer treatment-focused biotech ...

SpaceX’s potential $1.75T IPO could reshape markets. Learn how investors can gain exposure through XOVR ETF and why structure matters for returns and liquidity.

A potential initial public offering (IPO) next year by cryptocurrency exchange Kraken may attract fresh capital from traditional finance (TradFi) investors. Bitcoin recorded an all-time high price ...